Why is Leu55-->Pro55 transthyretin variant the most amyloidogenic: insights from molecular dynamics simulations of transthyretin monomers
- PMID: 12761393
- PMCID: PMC2323890
- DOI: 10.1110/ps.0239703
Why is Leu55-->Pro55 transthyretin variant the most amyloidogenic: insights from molecular dynamics simulations of transthyretin monomers
Abstract
Transthyretin (TTR) is one of the known human amyloidogenic proteins. Its native state is a homotetramer with each monomer having a beta-sandwich structure. Strong experimental evidence suggests that TTR dissociates into monomeric intermediates and that the monomers subsequently self-assemble to form amyloid deposits and insoluble fibrils. However, details on the early steps along the pathway of TTR amyloid formation are unclear, although various experimental approaches with resolutions at the molecular or residue level have provided some clues. It is highly likely that the stability and flexibility of monomeric TTR play crucial roles in the early steps of amyloid formation; thereby, it is essential to characterize initial conformational changes of TTR monomers. In this article we probe the possibility that the differences in the monomeric forms of wild-type (WT) TTR and its variants are responsible for differential amyloidogenesis. We begin with the simulations of WT, Val30-->Met (V30M), and Leu55-->Pro (L55P) TTR monomers. Nanosecond time scale molecular dynamics simulations at 300 K were performed using AMBER. The results indicate that the L55P-TTR monomer undergoes substantial structural changes relative to fluctuations observed in the WT and V30M TTR monomers. The observation supports earlier speculation that the L55P mutation may lead to disruption of the beta-sheet structure through the disorder of the "edge strands" that might facilitate amyloidogenesis.
Figures










Similar articles
-
Potentially amyloidogenic conformational intermediates populate the unfolding landscape of transthyretin: insights from molecular dynamics simulations.Protein Sci. 2010 Feb;19(2):202-19. doi: 10.1002/pro.289. Protein Sci. 2010. PMID: 19937650 Free PMC article.
-
Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation.Biochemistry. 1998 Dec 22;37(51):17851-64. doi: 10.1021/bi981876+. Biochemistry. 1998. PMID: 9922152
-
Initial conformational changes of human transthyretin under partially denaturing conditions.Biophys J. 2005 Jul;89(1):433-43. doi: 10.1529/biophysj.105.059642. Epub 2005 Apr 8. Biophys J. 2005. PMID: 15821170 Free PMC article.
-
Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid.Adv Protein Chem. 1997;50:161-81. doi: 10.1016/s0065-3233(08)60321-6. Adv Protein Chem. 1997. PMID: 9338081 Review.
-
Transthyretin mutagenesis: impact on amyloidogenesis and disease.Crit Rev Clin Lab Sci. 2024 Nov;61(7):616-640. doi: 10.1080/10408363.2024.2350379. Epub 2024 Jun 7. Crit Rev Clin Lab Sci. 2024. PMID: 38850014 Review.
Cited by
-
Simulation of pH-dependent edge strand rearrangement in human beta-2 microglobulin.Protein Sci. 2006 Jan;15(1):200-7. doi: 10.1110/ps.051814306. Epub 2005 Dec 1. Protein Sci. 2006. PMID: 16322574 Free PMC article.
-
Two distinct aggregation pathways in transthyretin misfolding and amyloid formation.Biochim Biophys Acta Proteins Proteom. 2019 Mar;1867(3):344-349. doi: 10.1016/j.bbapap.2018.10.013. Epub 2018 Oct 24. Biochim Biophys Acta Proteins Proteom. 2019. PMID: 30366153 Free PMC article.
-
Localized structural fluctuations promote amyloidogenic conformations in transthyretin.J Mol Biol. 2013 Mar 25;425(6):977-88. doi: 10.1016/j.jmb.2013.01.008. Epub 2013 Jan 11. J Mol Biol. 2013. PMID: 23318953 Free PMC article.
-
Phase diagrams describing fibrillization by polyalanine peptides.Biophys J. 2004 Dec;87(6):4122-34. doi: 10.1529/biophysj.104.047159. Epub 2004 Oct 1. Biophys J. 2004. PMID: 15465859 Free PMC article.
-
Potentially amyloidogenic conformational intermediates populate the unfolding landscape of transthyretin: insights from molecular dynamics simulations.Protein Sci. 2010 Feb;19(2):202-19. doi: 10.1002/pro.289. Protein Sci. 2010. PMID: 19937650 Free PMC article.
References
-
- Adams, D. and Said, G. 1996. Ultrastructural immunolabelling of amyloid fibrils in acquired and hereditary amyloid neuropathies. J. Neurol. 243 63–67. - PubMed
-
- Bashford, D. and Case, D.A. 2000. Generalized born models of macromolecular solvation effects. Annu. Rev. Phys. Chem. 51 129–152. - PubMed
-
- Batschelet, E. 1981. Circular statistics in biology. Academic Press, Inc., New York.
-
- Berendsen, H.J.C., Postma, J.P.M., van Gunsteren, W.F., DiNola, A., and Haak, J.R. 1984. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81 3684–3690.
-
- Blake, C.C., Geisow, M.J., Oatley, S.J., Rerat, B., and Rerat, C. 1978. Structure of prealbumin: Secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 Å. J. Mol. Biol. 121 339–356. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous